Cargando…
Limited role of patient input in specialty drug coverage policies
BACKGROUND: Despite increased financial contributions towards care, consumers’ role in shaping their insurance benefits is unclear. OBJECTIVE: To examine the role played by patient input when US commercial health plans formulate specialty drug coverage policies, along with the benefits and challenge...
Autores principales: | D’Cruz, Brittany, Graff, Jennifer S, Panzer, Ari D, Chambers, James D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391252/ https://www.ncbi.nlm.nih.gov/pubmed/34337996 http://dx.doi.org/10.18553/jmcp.2021.27.8.1067 |
Ejemplares similares
-
Specialty drug coverage varies between health plans’ medical and pharmacy benefit policies
por: Levine, A. Alex, et al.
Publicado: (2023) -
Variation in health plan specialty drug coverage: an empirical analysis
por: Margaretos, Nikoletta M., et al.
Publicado: (2019) -
The association between US Food and Drug Administration−expedited review designations and health plan specialty drug coverage
por: Panzer, Ari D, et al.
Publicado: (2023) -
Examining US commercial health plans’ use of The Institute for Clinical and Economic Review’s reports in specialty drug coverage decisions
por: Chambers, James D, et al.
Publicado: (2023) -
Characterizing health plan evidence review practices
por: Panzer, Ari D, et al.
Publicado: (2022)